+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review

Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Becton Dickinson and Co (BD) is a medical technology company, which manufactures and sells medical devices, reagents, and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; pre-fillable drug delivery systems; respiratory ventilation and diagnostic equipment and consumables; products for the safe collection and transportation of diagnostic specimens; instruments and reagent systems to detect a range of infectious diseases and cancers; and clinical research tools. BD offers its products for life science researchers, healthcare institutions, clinical laboratories, the pharmaceutical industry, and general public. The company markets its products in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. BD is headquartered in New Jersey, the US.

Becton Dickinson and Co Key Recent Developments

  • Apr 05, 2024: BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters
  • Mar 14, 2024: BD Collaborates with GOCC to Combat Sepsis in Poland
  • Mar 11, 2024: BD Names Rian Seger President of BD Surgery
  • Mar 04, 2024: AHF Urges WHO: Save Critical HIV Tech

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Becton Dickinson and Co - Key Facts
  • Becton Dickinson and Co - Key Employees
  • Becton Dickinson and Co - Key Employee Biographies
  • Becton Dickinson and Co - Major Products and Services
  • Becton Dickinson and Co - History
  • Becton Dickinson and Co - Company Statement
  • Becton Dickinson and Co - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Business Unit
Section 2 - Company Analysis
  • Company Overview
  • Becton Dickinson and Co - Business Description
  • Business Segment: Interventional
  • Overview
  • Performance
  • Business Segment: Life Sciences
  • Overview
  • Performance
  • Business Segment: Medical
  • Overview
  • Performance
  • Geographical Segment: EMEA
  • Target Markets
  • Performance
  • Geographical Segment: Greater Asia
  • Target Markets
  • Performance
  • Geographical Segment: Other
  • Target Markets
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Becton Dickinson and Co - Corporate Strategy
  • Becton Dickinson and Co - SWOT Analysis
  • SWOT Analysis - Overview
  • Becton Dickinson and Co - Strengths
  • Becton Dickinson and Co - Weaknesses
  • Becton Dickinson and Co - Opportunities
  • Becton Dickinson and Co - Threats
  • Becton Dickinson and Co - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Becton Dickinson and Co, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Becton Dickinson and Co, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Becton Dickinson and Co, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 05, 2024: BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters
  • Mar 14, 2024: BD Collaborates with GOCC to Combat Sepsis in Poland
  • Mar 11, 2024: BD Names Rian Seger President of BD Surgery
  • Mar 04, 2024: AHF Urges WHO: Save Critical HIV Tech
  • Feb 28, 2024: BD Names Nikos Pavlidis President of Diagnostic Solutions
  • Feb 27, 2024: Dave Hickey Announces Intent to Retire from BD
  • Feb 12, 2024: BD to Present Next Installment of BD Innovates Series: Spotlight on Peripheral Vascular Disease
  • Feb 01, 2024: BD Reports First Quarter Fiscal 2024 Financial Results
  • Nov 30, 2023: FDA Safety Communication Does Not Impact BD Syringes
  • Nov 21, 2023: BD Names Dr. Ronald Silverman as Chief Medical Officer
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Becton Dickinson and Co, Key Facts
  • Becton Dickinson and Co, Key Employees
  • Becton Dickinson and Co, Key Employee Biographies
  • Becton Dickinson and Co, Major Products and Services
  • Becton Dickinson and Co, History
  • Becton Dickinson and Co, Other Locations
  • Becton Dickinson and Co, Subsidiaries
  • Becton Dickinson and Co, Business Unit
  • Becton Dickinson and Co, Key Competitors
  • Becton Dickinson and Co, Ratios based on current share price
  • Becton Dickinson and Co, Annual Ratios
  • Becton Dickinson and Co, Annual Ratios (Cont...1)
  • Becton Dickinson and Co, Annual Ratios (Cont...2)
  • Becton Dickinson and Co, Interim Ratios
  • Becton Dickinson and Co, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Becton Dickinson and Co, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Becton Dickinson and Co, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Becton Dickinson and Co, Performance Chart (2019 - 2023)
  • Becton Dickinson and Co, Ratio Charts
  • Becton Dickinson and Co, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Becton Dickinson and Co, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Baxter International Inc
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Medtronic Plc
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Baxter International Inc
  • B. Braun Melsungen AG